Anti-Complement C3d, Goat-Poly

データシート※最新のデータシートでない場合があります

• 商品コード：AF2655
• メーカー：RSD
• 包装：100μg
• 価格： ¥83,000
• 在庫：1個

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Torzewski M et al. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice. Thromb. Haemost. 2008 Jan;99(1):196-201
  Torzewski M et al
  2008/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 2
• 文献情報：
  Leung VW et al. Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice. Am. J. Pathol. 2009 Oct;175(4):1757-67
  Leung VW et al
  2009/01/01
  
• 備考：
  Application: ELISA Development, Sample Type: Serum
• 参照：
  

• No.： 3
• 文献情報：
  Fan X et al. Induction of human blood group a antigen expression on mouse cells, using lentiviral gene transduction. Hum. Gene Ther. 2010 Jul;21(7):877-90
  Fan X et al
  2010/01/01
  
• 備考：
  Application: IHC Frozen, Sample Type: Whole Tissue
• 参照：
  

• No.： 4
• 文献情報：
  Atkinson C et al. Targeted complement inhibitors protect against posttransplant cardiac ischemia and reperfusion injury and reveal an important role for the alternative pathway of complement activation. J. Immunol. 2010 Dec;185(11):7007-13
  Atkinson C et al
  2010/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 5
• 文献情報：
  Zhao Z et al. Age-related retinopathy in NRF2-deficient mice. PLoS ONE 2011;6(4):e19456
  Zhao Z et al
  2011/01/01
  
• 備考：
  Application: IHC Frozen, Sample Type: Whole Tissue
• 参照：
  

• No.： 6
• 文献情報：
  Elvington A et al. Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J. Immunol. 2012 Feb;188(3):1460-8
  Elvington A et al
  2012/01/01
  
• 備考：
  Application: IHC Frozen,IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 7
• 文献情報：
  Elvington A et al. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J. Immunol. 2012 Nov;189(9):4640-7
  Elvington A et al
  2012/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 8
• 文献情報：
  Atkinson C et al. Donor brain death exacerbates complement-dependent ischemia/reperfusion injury in transplanted hearts. Circulation 2013 Mar;127(12):1290-9
  Atkinson C et al
  2013/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 9
• 文献情報：
  Khan MA et al. Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc. Natl. Acad. Sci. U.S.A. 2013 Apr;110(15):6061-6
  Khan MA et al
  2013/01/01
  
• 備考：
  Application: IHC OCT-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 10
• 文献情報：
  Abu-Humaidan AH et al. The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation. J. Immunol. 2014 Apr;192(7):3355-64
  Abu-Humaidan AH et al
  2014/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: tissue section
• 参照：
  

• No.： 11
• 文献情報：
  Zhang Y et al. Soluble CR1 therapy improves complement regulation in C3 glomerulopathy. J. Am. Soc. Nephrol. 2013 Nov;24(11):1820-9
  Zhang Y et al
  2013/01/01
  
• 備考：
  Application: IHC, Sample Type: Whole Tissue
• 参照：
  

• No.： 12
• 文献情報：
  Li Y et al. Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-β Signaling in the Retinal Pigment Epithelium. J. Biol. Chem. 2015 May;290(19):11918-34
  Li Y et al
  2015/01/01
  
• 備考：
  Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
• 参照：
  

• No.： 13
• 文献情報：
  Hu C et al. Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling. J. Immunol. 2018 12;201(12):3717-3730
  Hu C et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Platt JL et al. C3d regulates immune checkpoint blockade and enhances antitumor immunity. JCI Insight 2017 May;2(9)
  Platt JL et al
  2017/01/01
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Alawieh A et al. Acute Complement Inhibition Potentiates Neurorehabilitation and Enhances tPA-Mediated Neuroprotection. J. Neurosci. 2018 Jul;38(29):6527-6545
  Alawieh A et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Alawieh A et al. Identifying the Role of Complement in Triggering Neuroinflammation after Traumatic Brain Injury. J. Neurosci. 2018 03;38(10):2519-2532
  Alawieh A et al
  2018/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Itto R et al. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist. Tohoku J Exp Med 2019 10;249(2):127-133
  Itto R et al
  2019/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Hou B et al. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death Dis 2020 05;11(5):377
  Hou B et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 19
• 文献情報：
  Lu Y et al. Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain. J Neurosci 2020 09;40(38):7355-7374
  Lu Y et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：
  

• No.： 20
• 文献情報：
  Hijaze N et al. Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors. J Leukoc Biol 2021 08;110(2):343-356
  Hijaze N et al
  2021/01/01
  
• 備考：
  Species: Mouse, Applications: IHC
• 参照：
  

• No.： 21
• 文献情報：
  Jabri Y et al. Cell-Type-Specific Complement Profiling in the ABCA4^-/- Mouse Model of Stargardt Disease. Int J Mol Sci 2020 Nov;21(22)
  Jabri Y et al
  2020/01/01
  
• 備考：
  Species: Mouse, Applications: Western Blot
• 参照：